[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100653339":3},{"organization":4,"outcomesModule":7,"designInfo":39,"detailedDescription":38,"studyPopulation":38,"armGroups":51,"interventions":64,"overallOfficials":74,"centralContacts":78,"locations":83,"responsibleParty":100,"collaborators":38,"id":102,"slug":103,"hasResults":104,"nctId":105,"briefTitle":106,"officialTitle":107,"acronym":38,"eligibilityCriteria":108,"healthyVolunteers":104,"sex":109,"minAge":110,"maxAge":38,"enrollmentInfo":111,"targetDuration":38,"studyType":114,"phases":115,"briefSummary":117,"conditions":118,"keywords":120,"overallStatus":123,"whyStopped":38,"lastUpdateSubmitDate":124,"lastUpdatePostDateStruct":125,"startDateStruct":128,"completionDateStruct":130,"leadSponsor":132,"locationsCount":133},{"fullName":5,"class":6},"Icahn School of Medicine at Mount Sinai","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":38},[9],{"measure":10,"description":11,"timeFrame":12},"Morphine equivalents administered within 24 hours after spinal administration","The total sum of opiates will be converted into morphine equivalents and compared between the groups for the first 24 hours after the spinal is administered.","24 hours",[14,18,22,26,30,34],{"measure":15,"description":16,"timeFrame":17},"Morphine Equivalents at 48 Hours","The total sum of opiates will be converted into morphine equivalents and compared between the groups for the first 48 hours after the spinal is administered.","48 hours",{"measure":19,"description":20,"timeFrame":21},"Morphine Equivalents at 72 Hours","The total sum of opiates will be converted into morphine equivalents and compared between the groups for the first 72 hours after the spinal is administered.","72 hours",{"measure":23,"description":24,"timeFrame":25},"Obstetric Quality of Recovery-10 (ObsQoR-10) Score","Recovery score of the OBSQOR10 instrument at 24 hours, 48 hours, and 72 hours post spinal.\n\nObstetric Quality of Recovery-10 (ObsQoR-10) is a 10-item instrument. Full scale is scored from 0-100 with higher score indicating better health outcomes.","24 hours, 48 hours, and 72 hours post spinal administration",{"measure":27,"description":28,"timeFrame":29},"Pruritus Scores PACU","Pruritus scores full scale scored from 1-5 with higher score indicating more pruritus.","during PACU stay, about 6 hours",{"measure":31,"description":32,"timeFrame":33},"Pruritus Scores POD1-3","Pruritus scores full scale scored from 1-5 with higher score indicating more pruritus at 24 hour intervals for 3 days after spinal.","at 24 hours intervals for 72 hours",{"measure":35,"description":36,"timeFrame":37},"Floor Pain Scores over 24 hours","Pain scores obtain by nursing team over the first 24 hours while on regular hospital floor. Pain scored from 0-10, with higher score indicating more pain.","through 24 hours",null,{"allocation":40,"interventionModel":41,"interventionModelDescription":38,"primaryPurpose":42,"observationalModel":38,"timePerspective":38,"maskingInfo":43},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":44,"maskingDescription":45,"whoMasked":46},"QUADRUPLE","Assignments done via opaque envelopes. Separate team will break envelopes and draw up study medication.",[47,48,49,50],"PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR",[52,58],{"label":53,"type":54,"description":55,"interventionNames":56},"Buprenorphine","EXPERIMENTAL","Patients receive 60 mcg buprenorphine as a part of their spinal medications.",[57],"Drug: buprenorphine",{"label":59,"type":60,"description":61,"interventionNames":62},"Morphine","ACTIVE_COMPARATOR","Patients receive 125 mcg morphine as a part of their spinal medications",[63],"Drug: morphine",[65,70],{"type":66,"name":67,"description":68,"armGroupLabels":69,"otherNames":38},"DRUG","buprenorphine","60 mcg buprenorphine intrathecal",[53],{"type":66,"name":71,"description":72,"armGroupLabels":73,"otherNames":38},"morphine","125mcg morphine intrathecal",[59],[75],{"name":76,"affiliation":5,"role":77},"Daniel Katz","PRINCIPAL_INVESTIGATOR",[79],{"name":76,"role":80,"phone":81,"phoneExt":38,"email":82},"CONTACT","212-241-7475","daniel.katz@mountsinai.org",[84],{"facility":85,"status":38,"city":86,"state":86,"zip":87,"country":88,"countryCode":89,"cosmosGeoPoint":90,"geoPoint":95,"contacts":96},"Mount Sinai Hospital","New York","10029","United States","US",{"type":91,"coordinates":92},"Point",[93,94],-74.00597,40.71427,{"lat":94,"lon":93},[97,99],{"name":98,"role":80,"phone":81,"phoneExt":38,"email":82},"Daniel Katz, MD",{"name":76,"role":77,"phone":38,"phoneExt":38,"email":38},{"type":77,"investigatorFullName":76,"investigatorTitle":101,"investigatorAffiliation":5,"oldNameTitle":38,"oldOrganization":38},"Professor","100653339","phase-4-buprenorphine-versus-morphine-for-postcesarean-analgesia-bump-100653339",false,"NCT07786012","BUprenorphine Versus Morphine for Postcesarean Analgesia (BUMP)","The BUMP Trial: Intrathecal Buprenorphine Versus Morphine for Postcesarean Analgesia-A Randomized Noninferiority Trial","Inclusion Criteria:\n\n\\- Presenting for singleton elective cesarean delivery at term gestation.\n\nExclusion Criteria:\n\n* allergy to buprenorphine or morphine\n* will not have neuraxial anesthesia\n* chronic pain conditions\n* opiate based medications","ALL","19 Years",{"count":112,"type":113},180,"ESTIMATED","INTERVENTIONAL",[116],"PHASE4","In this study the researchers are randomizing pregnant patients coming for elective cesarean delivery to receive either intrathecal buprenorphine or morphine for their analgesia.",[119],"Cesarean Delivery",[119,121,122],"Pregnancy","postop pain","NOT_YET_RECRUITING","2026-09-21",{"date":126,"type":127},"2026-09-23","ACTUAL",{"date":129,"type":113},"2026-09-15",{"date":131,"type":113},"2028-08",{"name":5,"class":6},1]